Concord Drugs Limited (CONCORD.BO)
INR 30.97
(-1.05%)
INR 30.97
(-1.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 91.83 Million INR | 14.85% |
| 2022 | 79.95 Million INR | 4.38% |
| 2021 | 76.6 Million INR | 21.83% |
| 2020 | 62.87 Million INR | -6.95% |
| 2019 | 67.56 Million INR | 9.5% |
| 2018 | 61.7 Million INR | 3.18% |
| 2017 | 59.8 Million INR | -28.67% |
| 2016 | 83.84 Million INR | 31.97% |
| 2015 | 63.53 Million INR | 20.88% |
| 2014 | 52.55 Million INR | 115.43% |
| 2013 | 24.39 Million INR | 33.39% |
| 2012 | 18.28 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 21.77 Million INR | -40.1% |
| 2023 FY | 91.83 Million INR | 14.85% |
| 2023 Q4 | 24.34 Million INR | 0.47% |
| 2023 Q3 | 24.22 Million INR | 10.09% |
| 2023 Q2 | 22 Million INR | 3.96% |
| 2023 Q1 | 21.17 Million INR | 178.96% |
| 2022 Q4 | 7.58 Million INR | -72.43% |
| 2022 FY | 79.95 Million INR | 4.38% |
| 2022 Q3 | 27.53 Million INR | 19.14% |
| 2022 Q2 | 23.1 Million INR | 6.36% |
| 2022 Q1 | 21.72 Million INR | 87.05% |
| 2021 Q1 | 26.11 Million INR | 42.18% |
| 2021 Q2 | 20.22 Million INR | -22.58% |
| 2021 Q4 | 11.61 Million INR | -37.69% |
| 2021 Q3 | 18.64 Million INR | -7.81% |
| 2021 FY | 76.6 Million INR | 21.83% |
| 2020 Q4 | 18.37 Million INR | 2.1% |
| 2020 FY | 62.87 Million INR | -6.95% |
| 2020 Q3 | 17.99 Million INR | -3.15% |
| 2020 Q1 | 15.97 Million INR | 0.36% |
| 2020 Q2 | 18.57 Million INR | 16.26% |
| 2019 FY | 67.56 Million INR | 9.5% |
| 2019 Q2 | 18.6 Million INR | 20.86% |
| 2019 Q4 | 15.92 Million INR | -7.06% |
| 2019 Q3 | 17.13 Million INR | -7.91% |
| 2019 Q1 | 15.39 Million INR | 909.18% |
| 2018 Q2 | 18.14 Million INR | 10.75% |
| 2018 FY | 61.7 Million INR | 3.18% |
| 2018 Q4 | 1.52 Million INR | -93.35% |
| 2018 Q1 | 16.38 Million INR | 422.86% |
| 2018 Q3 | 22.92 Million INR | 26.32% |
| 2017 Q1 | 15.74 Million INR | -41.67% |
| 2017 FY | 59.8 Million INR | -28.67% |
| 2017 Q4 | -5.07 Million INR | -117.75% |
| 2017 Q3 | 28.59 Million INR | 32.18% |
| 2017 Q2 | 21.63 Million INR | 37.44% |
| 2016 Q1 | 17.41 Million INR | -12.89% |
| 2016 FY | 83.84 Million INR | 31.97% |
| 2016 Q3 | 22.34 Million INR | 20.48% |
| 2016 Q4 | 26.98 Million INR | 20.78% |
| 2016 Q2 | 18.54 Million INR | 6.51% |
| 2015 Q4 | 19.99 Million INR | 14.35% |
| 2015 Q2 | 12.39 Million INR | 178.12% |
| 2015 Q1 | 4.45 Million INR | 187.03% |
| 2015 FY | 63.53 Million INR | 20.88% |
| 2015 Q3 | 17.48 Million INR | 41.04% |
| 2014 Q1 | 14.09 Million INR | 17.8% |
| 2014 FY | 52.55 Million INR | 115.43% |
| 2014 Q4 | 1.55 Million INR | -86.14% |
| 2014 Q3 | 11.2 Million INR | -23.43% |
| 2014 Q2 | 14.63 Million INR | 3.82% |
| 2013 Q3 | 6.43 Million INR | 7.31% |
| 2013 Q2 | 5.99 Million INR | 3.95% |
| 2013 Q4 | 11.96 Million INR | 85.96% |
| 2013 FY | 24.39 Million INR | 33.39% |
| 2013 Q1 | 5.76 Million INR | 53.98% |
| 2012 FY | 18.28 Million INR | 0.0% |
| 2012 Q4 | 3.74 Million INR | -25.11% |
| 2012 Q3 | 5 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 277.6 Million INR | 66.919% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 41.451% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -457.673% |
| MedPlus Health Services Limited | 2.42 Billion INR | 96.212% |
| ANG Lifesciences India Limited | 219.92 Million INR | 58.245% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 37.327% |
| Bacil Pharma Limited | 1.87 Million INR | -4799.301% |
| BDH Industries Limited | 57.03 Million INR | -61.018% |
| Beryl Drugs Limited | 93.77 Million INR | 2.068% |
| Cian Healthcare Limited | 59.19 Million INR | -55.124% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -4616.59% |
| Deccan Health Care Limited | 36.24 Million INR | -153.386% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 30.65% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -3420.569% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 78.996% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 38.583% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 63.11% |
| Makers Laboratories Limited | 83.1 Million INR | -10.503% |
| Medi-Caps Limited | 93.11 Million INR | 1.381% |
| Panchsheel Organics Limited | 68.15 Million INR | -34.732% |
| Parmax Pharma Limited | 99.31 Million INR | 7.537% |
| Parnax Lab Limited | 80.59 Million INR | -13.947% |
| Patidar Buildcon Limited | 1.81 Million INR | -4970.79% |
| Phaarmasia Limited | 50.52 Million INR | -81.752% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 11.934% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 56.036% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -5925.722% |
| Smruthi Organics Limited | 261.73 Million INR | 64.914% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -188.263% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 37.141% |
| Trident Lifeline Limited | 46.87 Million INR | -95.925% |
| Transchem Limited | 8.47 Million INR | -983.819% |
| Trinity League India Limited | -1.08 Million INR | 8555.985% |
| Tyche Industries Limited | 182.04 Million INR | 49.554% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -355.38% |
| Vivanza Biosciences Limited | 4.55 Million INR | -1916.07% |
| PRAVEG LIMITED | 77.18 Million INR | -18.981% |
| Sastasundar Ventures Limited | 846.78 Million INR | 89.155% |
| Sunil Healthcare Limited | 438.1 Million INR | 79.039% |
| Syschem (India) Limited | 64.13 Million INR | -43.192% |
| Zenith Healthcare Limited | 45.97 Million INR | -99.73% |
| Zenlabs Ethica Limited | 57.89 Million INR | -58.618% |
| Mercury Laboratories Limited | 217.24 Million INR | 57.728% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -646.571% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 36.888% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 50.114% |
| Roopa Industries Limited | 24.63 Million INR | -272.77% |
| PANJON LTD. | 33.77 Million INR | -171.861% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -20.051% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -85724.299% |
| Anuh Pharma Limited | 263.04 Million INR | 65.089% |
| Crestchem Limited | 50.8 Million INR | -80.763% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -2024.757% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 56.866% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 74.524% |
| Trimurthi Limited | 4.81 Million INR | -1808.792% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -10.57% |
| Norris Medicines Limited | 18.2 Million INR | -404.429% |
| Veerhealth Care Limited | 15.38 Million INR | -497.009% |
| Lactose (India) Limited | 111.66 Million INR | 17.759% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -286.173% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 67.3% |
| Gennex Laboratories Limited | 130.37 Million INR | 29.564% |
| Denis Chem Lab Limited | 453.36 Million INR | 79.744% |
| Colinz Laboratories Limited | 31.19 Million INR | -194.352% |
| Godavari Drugs Limited | 359.01 Million INR | 74.421% |
| Zenotech Laboratories Limited | 94.82 Million INR | 3.153% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 11.814% |
| Bharat Parenterals Limited | 255.97 Million INR | 64.125% |
| Coral Laboratories Limited | 189.75 Million INR | 51.606% |
| Evoq Remedies Limited | 4.51 Million INR | -1933.031% |
| Kerala Ayurveda Limited | 399.64 Million INR | 77.022% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -3602.903% |
| Natural Capsules Limited | 444.7 Million INR | 79.35% |
| Auro Laboratories Limited | 157.37 Million INR | 41.648% |